EUCTR2004-004957-24-IT进行中（未招募）不适用
EUROPEAN COOPERATIVE STUDY OF PRIMARY SYSTEMIC THERAPY IN WOMEN WITH OPERABLE BREAST CANCER AND T < 2 CM
FONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI0 个研究点目标入组 160 人开始时间: 2005年7月12日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
European Cooperative Study of Primary Systemic Therapyin Women with Operable Breast Cancer and T > 2 cm - ECTO IIWomen presenting for the first time with operable breast cancer who have not received any previous treatment for an invasive malignancy.EUCTR2004-004957-24-ATFondazione Michelangelo486
已完成
不适用
European Cooperative Study of Primary Systemic Therapy in Women with Operable Breast Cancer and T > 2 cmEarly invasive unilateral breast cancer larger than 2 cm in diameterMalignant neoplasm of breastCancerISRCTN96423607Fondazione Michelangelo (Italy)486
进行中（未招募）
不适用
European Cooperative Study of Primary Systemic Therapyin Women with Operable Breast Cancer and T > 2 cmEstudio Cooperativo Europeo de Terapia Sistémica Primaria en Mujeres con Cáncer de Mama Operable y T > 2cm - ECTO IIWomen presenting for the first time with operable breast cancer who have not received any previous treatment for an invasive malignancy.EUCTR2004-004957-24-ESFondazione Michelangelo486
进行中（未招募）
不适用
European Cooperative Study of Primary Systemic Therapyin Women with Operable Breast Cancer and T > 2 cm - ECTO IIEUCTR2004-004957-24-DEFondazione Michelangelo486
招募中
不适用
Prospective, European collaborative multicenter observational study of standardized, ontogenetically based radical surgery in endometrial cancer FIGO IAG3 and stage IB to III by peritoneal mesometrial resection and therapeutic lymphadenectomy (PMMR/tLNE) without additional radiotherapyC54Malignant neoplasm of corpus uteriDRKS00016541niversitätsklinikum Essen500